RESPONSE OF PRIMARY THORACIC DISEASE TO CHEMORADIOTHERAPY CORRELATES WITH BRAIN-METASTASIS FREE SURVIVAL IN LIMITED-DISEASE SMALL-CELL LUNG CANCER PATIENTS WITH POOR INITIAL PERFORMANCE STATUS WHO SUCCESSFULLY COMPLETED MULTIMODALITY TREATMENT

被引：0
|
作者：
Manapov, F. [1 ]
Kloecking, S. [2 ]
Niyazi, M. [1 ]
Levitskiy, V. [2 ]
Belka, C. [1 ]
Hildebrandt, G. [2 ]
Fietkau, R. [3 ]
Klautke, G. [3 ]
机构：
[1] Univ Klinikum Munchen, Munich, Germany
[2] Univ Klinikum Rostock, Rostock, Germany
[3] Univ Klinikum Erlangen Nurnberg, Erlangen, Germany
来源：
LUNG CANCER | 2011年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 43 条
  • [31] Severe exacerbation or manifestation of primary disease related to nivolumab in non-small-cell lung cancer patients with poor performance status or brain metastases
    Kanai, O.
    Fujita, K.
    Okamura, M.
    Nakatani, K.
    Mio, T.
    ANNALS OF ONCOLOGY, 2016, 27 (07) : 1354 - 1356
  • [32] Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer
    Morimoto, Masahiro
    Okishio, Kyoichi
    Akira, Masanori
    Omachi, Naoki
    Tamiya, Akihiro
    Asami, Kazuhiro
    Kawaguchi, Tomoya
    Atagi, Shinji
    CLINICAL LUNG CANCER, 2017, 18 (02) : E117 - E127
  • [33] Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902
    Saito, Hiroshi
    Takada, Yoshiki
    Ichinose, Yukito
    Eguchi, Kenji
    Kudoh, Shinzoh
    Matsui, Kaoru
    Nakagawa, Kazuhiko
    Takada, Minoru
    Negoro, Shunichi
    Tamura, Kenji
    Ando, Masahiko
    Tada, Takuhito
    Fukuoka, Masahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) : 5247 - 5252
  • [34] Immunotherapy Improves Survival in Non-small Cell Lung Cancer Patients who Require Systemic Therapy for Recurrent Disease After Definitive Multimodality Treatment
    Voong, K. R.
    Hooker, C.
    Senter, J.
    Forde, P.
    Lang, M.
    Brock, M.
    Hales, R. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E499 - E499
  • [35] Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real-life Limited-disease Small-cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging
    Eze, Chukwuka
    Roengvoraphoj, Olarn
    Niyazi, Maximilian
    Hildebrandt, Guido
    Fietkau, Rainer
    Belka, Claus
    Manapov, Farkhad
    CLINICAL LUNG CANCER, 2017, 18 (04) : E243 - E249
  • [36] Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604
    Yuki Misumi
    Hiroaki Okamoto
    Jiichiro Sasaki
    Noriyuki Masuda
    Mari Ishii
    Tsuneo Shimokawa
    Yukio Hosomi
    Yusuke Okuma
    Makoto Nagamata
    Takashi Ogura
    Terufumi Kato
    Masafumi Sata
    Sakiko Otani
    Akira Takakura
    Koichi Minato
    Yosuke Miura
    Takuma Yokoyama
    Saori Takata
    Katsuhiko Naoki
    Koshiro Watanabe
    BMC Cancer, 17
  • [37] Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604
    Misumi, Yuki
    Okamoto, Hiroaki
    Sasaki, Jiichiro
    Masuda, Noriyuki
    Ishii, Mari
    Shimokawa, Tsuneo
    Hosomi, Yukio
    Okuma, Yusuke
    Nagamata, Makoto
    Ogura, Takashi
    Kato, Terufumi
    Sata, Masafumi
    Otani, Sakiko
    Takakura, Akira
    Minato, Koichi
    Miura, Yosuke
    Yokoyama, Takuma
    Takata, Saori
    Naoki, Katsuhiko
    Watanabe, Koshiro
    BMC CANCER, 2017, 17 (1)
  • [38] Maximum treatment response and prophylactic cranial irradiation are important prognostic factors in limited disease small-cell lung cancer patients comprehensively staged with cranial magnetic resonance imaging
    Eze, C.
    Roengvoraphoj, O.
    Niyazi, M.
    Gerum, S.
    Hildebrandt, G.
    Fietkau, R.
    Belka, C.
    Manapov, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 119 - 119
  • [39] Maximum treatment response and prophylactic cranial irradiation are important prognostic factors in limited disease small-cell lung cancer patients comprehensively staged with cranial magnetic resonance imaging
    Eze, C.
    Roengvoraphoj, O.
    Gerum, S.
    Belka, C.
    Manapov, F.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S111 - S111
  • [40] Evaluating the safety of using G-CSF prophylaxis during concurrent thoracic chemo-radiotherapy (CTRT) in patients with limited-disease small-cell lung cancer (LD-SCLC): Evidence from a phase II trial
    Sheikh, H. Y.
    Colaco, R.
    Ashcroft, L.
    Blackhall, F. H.
    Lorigan, P. C.
    Taylor, P.
    Thatcher, N.
    LUNG CANCER, 2010, 67 : S10 - S11
12345